APA citiranje

Wang, W., Grossauer, S., Koeck, K., Simonds, E., Lu, E., Bergers, G., . . . Petritsch, C. (2019). TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA. Neuro Oncol.

Citação norma Chicago

Wang, Wei, Stefan Grossauer, Katharina Koeck, Erin Simonds, Edbert Lu, Gabriele Bergers, William Weiss, and Claudia Petritsch. "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA." Neuro Oncol 2019.

MLA citiranje

Wang, Wei, et al. "TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA." Neuro Oncol 2019.